Expanding Our Understanding of COPD: The Role of IL-33 in Chronic Airway Inflammation

May 18 @ 6:30 pm 7:30 pm PDT

Hyatt SOMA – Gallery Ballroom 1-3
Sponsored by: Sanofi & Regeneron


Program Details

Join Sanofi and Regeneron, together with leading pulmonologists, for a focused discussion on the burden of COPD, the role of IL-33 in disease pathophysiology, and key insights from clinical trials. Participate in the live Q&A session following the presentations to hear directly from global experts in pulmonology.

Learning Objectives:

  • Communicate the burden of COPD, including its impact on patients’ QoL and the unmet needs that persist​
  • Describe the role of IL-33 in the pathophysiology of COPD, including its contribution to inflammation, airway remodeling, and disease progression​
  • Understand the clinical trial data investigating the impact of targeting the IL-33 pathway in COPD

Speakers

Presenter: Lauren Cohn, MD, PhD
Yale School of Medicine
Professor of Medicine
New Haven, Connecticut

Presenter: Klaus Rabe, MD, PhD, FERS
University of Kiel
Professor of Medicine
Kiel Germany

Presenter: Nicola Hanania, MD, MS, FCCP, FACP, FRCP, FERS
Baylor College of Medicine
Professor of Medicine
Houston, Texas